Clinical efficacy of low‐dose Perampanel correlates with neurophysiological changes in familial adult myoclonus epilepsy 2 by Antonietta Coppola, Claudia Cuccurullo, Gianmaria Senerchia, Marica Rubino, Liana Veneziano, Francesco Brancati, Luigi Baratto, Valentina Virginia Iuzzolino, Leonilda Bilo, Pasquale Striano, Raffaele Dubbioso

“…Abstract Familial adult myoclonus epilepsy (FAME) management relies on antiseizure medications (ASMs), which inadequately address myoclonus and cortical tremor. …”
Get full text

Clinical characteristics, etiology, and treatment of young adult‐onset epilepsy: A 24‐year retrospective study by Xu Zhang, Feng Xiang, Ziyu Wang, Yang Li, Chenjing Shao, Xiaoyang Lan, Senyang Lang, Xiangqing Wang

“…Methods The study included patients with epilepsy aged between 18 and 44 years and aimed to analyze the clinical characteristics of epilepsy in young people and their response to antiseizure medication (ASM) over a 24‐year period (February 1999 and March 2023). …”
Get full text